Stock listing
Amarantus Bioscience Holdings, Inc.
Selected listing: AMBS · OTC · USD · US
Amarantus Bioscience Holdings, Inc. (OTC:AMBS), Health Technology. Latest release Apr 27, 2022: Amarantus Signs Non-Binding Term Sheet to Divest Cutanogen…
- Ticker
- OTC:AMBS
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
About Amarantus Bioscience Holdings, Inc.
Amarantus Bioscience Holdings, Inc. is a public company traded under the ticker AMBS in the American market. Amarantus focuses on developing innovative therapies and diagnostics in the biotechnology sector.
Latest news from Amarantus Bioscience Holdings, Inc.
Amarantus Signs Non-Binding Term Sheet to Divest Cutanogen Corporation in Exchange for the Extinguishment of Potential $21M+ in Liabilities
April 26, 2022
Todos Medical Enters into Exclusive COVID-19 Testing Supply Agreement with MOTO+PARA’s National Mobile CLIA Lab Partner Integrated Health
October 7, 2020
Todos Medical Enters Into COVID-19 PCR Testing Implementation and Equipment Financing Partnership with AID Genomics
September 25, 2020
Todos Medical Expands Existing Contract for COVID-19 PCR Testing Equipment & Supplies with Wisconsin-based Laboratory to $47.5 Million
September 22, 2020
Todos Medical CEO Releases Letter to Shareholders
September 18, 2020
Research Amarantus Bioscience Holdings, Inc.
Amarantus Bioscience Holdings, Inc. company profile
View the public company page for Amarantus Bioscience Holdings, Inc. on 6ix.
Amarantus Bioscience Holdings, Inc. news
Read company news and market updates connected to Amarantus Bioscience Holdings, Inc..
Amarantus Bioscience Holdings, Inc. investor events
Find investor webinars, events, and replay context for Amarantus Bioscience Holdings, Inc..